IDEXX Laboratories Revenue 2010-2024 | IDXX
IDEXX Laboratories annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IDEXX Laboratories revenue for the quarter ending September 30, 2024 was $0.976B, a 6.56% increase year-over-year.
- IDEXX Laboratories revenue for the twelve months ending September 30, 2024 was $3.845B, a 7.16% increase year-over-year.
- IDEXX Laboratories annual revenue for 2023 was $3.661B, a 8.72% increase from 2022.
- IDEXX Laboratories annual revenue for 2022 was $3.367B, a 4.73% increase from 2021.
- IDEXX Laboratories annual revenue for 2021 was $3.215B, a 18.79% increase from 2020.
| IDEXX Laboratories Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $3,661 |
| 2022 | $3,367 |
| 2021 | $3,215 |
| 2020 | $2,707 |
| 2019 | $2,407 |
| 2018 | $2,213 |
| 2017 | $1,969 |
| 2016 | $1,775 |
| 2015 | $1,602 |
| 2014 | $1,486 |
| 2013 | $1,377 |
| 2012 | $1,293 |
| 2011 | $1,219 |
| 2010 | $1,103 |
| 2009 | $1,032 |
| IDEXX Laboratories Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $976 |
| 2024-06-30 | $1,004 |
| 2024-03-31 | $964 |
| 2023-12-31 | $902 |
| 2023-09-30 | $916 |
| 2023-06-30 | $944 |
| 2023-03-31 | $900 |
| 2022-12-31 | $829 |
| 2022-09-30 | $842 |
| 2022-06-30 | $861 |
| 2022-03-31 | $837 |
| 2021-12-31 | $801 |
| 2021-09-30 | $810 |
| 2021-06-30 | $826 |
| 2021-03-31 | $778 |
| 2020-12-31 | $721 |
| 2020-09-30 | $722 |
| 2020-06-30 | $638 |
| 2020-03-31 | $626 |
| 2019-12-31 | $605 |
| 2019-09-30 | $605 |
| 2019-06-30 | $620 |
| 2019-03-31 | $576 |
| 2018-12-31 | $549 |
| 2018-09-30 | $545 |
| 2018-06-30 | $581 |
| 2018-03-31 | $538 |
| 2017-12-31 | $506 |
| 2017-09-30 | $492 |
| 2017-06-30 | $509 |
| 2017-03-31 | $462 |
| 2016-12-31 | $443 |
| 2016-09-30 | $448 |
| 2016-06-30 | $467 |
| 2016-03-31 | $418 |
| 2015-12-31 | $400 |
| 2015-09-30 | $406 |
| 2015-06-30 | $413 |
| 2015-03-31 | $382 |
| 2014-12-31 | $352 |
| 2014-09-30 | $384 |
| 2014-06-30 | $390 |
| 2014-03-31 | $360 |
| 2013-12-31 | $354 |
| 2013-09-30 | $338 |
| 2013-06-30 | $353 |
| 2013-03-31 | $332 |
| 2012-12-31 | $320 |
| 2012-09-30 | $315 |
| 2012-06-30 | $336 |
| 2012-03-31 | $323 |
| 2011-12-31 | $307 |
| 2011-09-30 | $301 |
| 2011-06-30 | $318 |
| 2011-03-31 | $293 |
| 2010-12-31 | $284 |
| 2010-09-30 | $270 |
| 2010-06-30 | $281 |
| 2010-03-31 | $269 |
| 2009-12-31 | $270 |
| 2009-09-30 | $259 |
| 2009-06-30 | $266 |
| 2009-03-31 | $236 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.758B | $3.661B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| AxoGen (AXGN) | United States | $0.688B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.142B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |